Total Payments
$1,110
2024 Payments
$795.00
Companies
18
Transactions
55
Medicare Patients
976
Medicare Billing
$153,626
Payment Breakdown by Category
Food & Beverage$1,110 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,110 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $313.85 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $239.54 | 12 | $0 (2024) |
| Philips Electronics North America Corporation | $87.57 | 3 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $80.94 | 5 | $0 (2024) |
| Inspire Medical Systems, Inc. | $61.00 | 3 | $0 (2024) |
| Mylan Specialty L.P. | $49.96 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.26 | 2 | $0 (2024) |
| GENZYME CORPORATION | $38.71 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $31.90 | 1 | $0 (2023) |
| Vapotherm Inc | $26.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $795.00 | 41 | GlaxoSmithKline, LLC. ($278.02) |
| 2023 | $199.43 | 10 | AstraZeneca Pharmaceuticals LP ($78.30) |
| 2022 | $115.21 | 4 | Philips Electronics North America Corporation ($72.88) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Vapotherm Inc | VAPOTHERM (Device) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.61 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: COVID-19 | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROLOGY | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardiology | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/31/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: NEUROLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 717 | 1,089 | $214,245 | $114,861 |
| 2022 | 11 | 259 | 366 | $71,989 | $38,765 |
Total Patients
976
Total Services
1,455
Medicare Billing
$153,626
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 101 | 287 | $89,544 | $50,046 | 55.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 98 | $23,520 | $14,115 | 60.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 215 | $26,875 | $13,784 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 119 | $20,230 | $11,726 | 58.0% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 50 | 66 | $10,140 | $5,751 | 56.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $7,410 | $4,952 | 66.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 32 | $7,296 | $3,233 | 44.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 59 | 59 | $5,900 | $2,685 | 45.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $3,250 | $2,192 | 67.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 58 | 58 | $5,800 | $2,027 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 32 | $4,000 | $1,943 | 48.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,815 | $931.20 | 51.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 38 | 38 | $5,130 | $812.16 | 15.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 23 | 23 | $3,335 | $663.63 | 19.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 46 | 123 | $38,376 | $22,120 | 57.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 68 | $8,500 | $3,981 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 25 | $4,250 | $2,593 | 61.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $2,925 | $2,106 | 72.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 29 | 29 | $2,900 | $1,467 | 50.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,192 | $1,452 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $2,250 | $1,250 | 55.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,145 | $1,229 | 57.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 29 | 29 | $2,900 | $1,088 | 37.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 11 | 11 | $1,716 | $994.18 | 57.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 21 | 21 | $2,835 | $482.79 | 17.0% |
About Dr. Ryan Townsend, M.D
Dr. Ryan Townsend, M.D is a Pulmonary Disease healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1194188375.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Townsend, M.D has received a total of $1,110 in payments from pharmaceutical and medical device companies, with $795.00 received in 2024. These payments were reported across 55 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,110).
As a Medicare-enrolled provider, Townsend has provided services to 976 Medicare beneficiaries, totaling 1,455 services with total Medicare billing of $153,626. Data is available for 2 years (2022–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Marlton, NJ
- Active Since 04/04/2016
- Last Updated 12/09/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194188375
Products in Payments
- AREXVY (Drug) $125.00
- NUCALA (Biological) $97.57
- TRELEGY ELLIPTA (Drug) $91.28
- (8874) inCourage (Device) $87.57
- OPSUMIT (Drug) $80.94
- AIRSUPRA (Drug) $72.44
- TEZSPIRE (Biological) $67.24
- FASENRA (Biological) $61.49
- INSPIRE (Device) $61.00
- DUPIXENT (Biological) $59.66
- ARALAST (Biological) $45.26
- BREZTRI (Drug) $38.37
- XOLAIR (Drug) $31.90
- YUPELRI (Drug) $29.19
- VAPOTHERM (Device) $26.67
- Yupelri (Drug) $20.77
- OFEV (Drug) $18.67
- Adempas (Drug) $17.00
- XYWAV (Drug) $17.00
- (AK6) Vest Therapy (Device) $15.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Marlton
Dr. Mark Weir, Mb Chb, MB CHB
Pulmonary Disease — Payments: $7,553
Pulmonary Disease $7,553
Dr. Eric Sztejman, Md, MD
Pulmonary Disease — Payments: $4,910
Pulmonary Disease $4,910
Dr. Emilio Mazza, Md, MD
Pulmonary Disease — Payments: $4,892
Pulmonary Disease $4,892
Allen Salm, Md, MD
Pulmonary Disease — Payments: $4,688
Pulmonary Disease $4,688
Abhishek Agarwal, Md, MD
Pulmonary Disease — Payments: $4,388
Pulmonary Disease $4,388
Matthew Gordon, Md, MD
Pulmonary Disease — Payments: $4,385
Pulmonary Disease $4,385